JLB & Associates Inc. lifted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 5.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 85,066 shares of the company’s stock after purchasing an additional 4,278 shares during the period. JLB & Associates Inc. owned about 0.06% of Henry Schein worth $5,000,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Ardevora Asset Management LLP acquired a new position in shares of Henry Schein in the second quarter worth about $43,876,000. Nordea Investment Management AB increased its stake in shares of Henry Schein by 99.6% in the 2nd quarter. Nordea Investment Management AB now owns 1,259,360 shares of the company’s stock valued at $72,766,000 after purchasing an additional 628,306 shares in the last quarter. Wedge Capital Management L L P NC boosted its position in Henry Schein by 3,344.2% during the third quarter. Wedge Capital Management L L P NC now owns 429,727 shares of the company’s stock worth $25,259,000 after purchasing an additional 417,250 shares in the last quarter. AXA boosted its position in Henry Schein by 183.7% during the first quarter. AXA now owns 544,653 shares of the company’s stock worth $27,516,000 after purchasing an additional 352,647 shares in the last quarter. Finally, Sound Shore Management Inc CT boosted its position in Henry Schein by 32.2% during the second quarter. Sound Shore Management Inc CT now owns 1,437,167 shares of the company’s stock worth $83,916,000 after purchasing an additional 350,379 shares in the last quarter. 99.97% of the stock is currently owned by hedge funds and other institutional investors.
In other Henry Schein news, EVP Gerald A. Benjamin sold 14,430 shares of the business’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $68.08, for a total value of $982,394.40. Following the transaction, the executive vice president now directly owns 114,189 shares in the company, valued at approximately $7,773,987.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.05% of the stock is owned by insiders.
Shares of HSIC traded up $0.98 during mid-day trading on Friday, reaching $62.34. The stock had a trading volume of 772,790 shares, compared to its average volume of 1,553,426. Henry Schein, Inc. has a 52-week low of $41.85 and a 52-week high of $73.99. The firm has a market cap of $8.90 billion, a price-to-earnings ratio of 15.51, a P/E/G ratio of 3.76 and a beta of 1.00. The business’s fifty day moving average is $61.96 and its 200 day moving average is $59.77. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.48 and a quick ratio of 0.87.
Several research analysts have recently weighed in on the company. Zacks Investment Research raised Henry Schein from a “sell” rating to a “hold” rating and set a $71.00 target price for the company in a research note on Monday, July 20th. TheStreet cut shares of Henry Schein from a “b” rating to a “c+” rating in a research report on Tuesday, August 4th. BidaskClub raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Saturday. Finally, ValuEngine downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Friday, August 7th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $64.33.
Henry Schein Company Profile
Henry Schein, Inc, a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also: Buy-Side Analysts
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.